The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125836471 12583647 1 I 20160712 20160722 20160722 EXP JP-HQ SPECIALTY-JP-2016INT000588 INTERCHEM GOTO A, ITOH M, WAKASUGI H, KANNO S, YABANA T, MITSUHASHI K, ET AL. A CASE OF RECURRENT GASTRIC CANCER SHOWING PARTIAL RESPONSE TO CAPECITABINE/CDDP AFTER TREATMENT WITH S-1/ CDDP. GAN TO KAGAKU RYOHO. 2012;39 (10):1563-1566 71.00 YR M Y 0.00000 20160722 OT JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125836471 12583647 1 PS CISPLATIN. CISPLATIN 1 Unknown 60 MG/M2, ON DAY 8, ONCE EVERY 5 WEEKS 18057 60 MG/M**2
125836471 12583647 2 SS CISPLATIN. CISPLATIN 1 Unknown 60 MG/M2, ON DAY 1 ONCE EVEY 3 WEEKS 18057 60 MG/M**2
125836471 12583647 3 SS CAPECITABINE. CAPECITABINE 1 Unknown 3000 MG, QD ON DAY 1-14 0 3000 MG
125836471 12583647 4 SS CAPECITABINE. CAPECITABINE 1 Unknown 400 MG, QD FROM THIRD CYCLE 0 400 MG
125836471 12583647 5 SS TS-1 GIMERACILOTERACILTEGAFUR 1 Unknown UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125836471 12583647 1 Gastric cancer
125836471 12583647 3 Gastric cancer
125836471 12583647 5 Gastric cancer

Outcome of event

Event ID CASEID OUTC COD
125836471 12583647 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125836471 12583647 Decreased appetite
125836471 12583647 Haematotoxicity
125836471 12583647 Nausea

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125836471 12583647 2 20110614 0
125836471 12583647 3 20110614 0